Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Surgical Oncology|November 13, 2022
Clinical significance of cachexia index in patients with hepatocellular carcinoma after hepatic resectionMunetoshi Akaoka, Koichiro Haruki, Tomohiko Taniai, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 8, 2026
Tumor Endothelial Cell-Derived Extracellular Vesicles Promote Hepatocellular Carcinoma Progression Through Intercellular Interaction Via miRNAMitsuru Yanagaki, Koichiro Haruki, Munetoshi Akaoka, et al.
Surgery Today|April 29, 2025
The minimum apparent diffusion coefficient value on preoperative magnetic resonance imaging in resectable pancreatic cancer: a new prognostic factor for biologically borderline resectable pancreatic cancerMichinori Matsumoto, Masashi Tsunematsu, Ryoga Hamura, et al.
Annals of Surgical Oncology|January 3, 2025
ARID4B Promotes the Progression of Hepatocellular Carcinoma Through the PI3K/AKT PathwayMunetoshi Akaoka, Mitsuru Yanagaki, Hoshiho Kubota, et al.
Annals of Gastroenterological Surgery|May 8, 2023
The impact of C-reactive protein-albumin-lymphocyte (CALLY) index on the prognosis of patients with distal cholangiocarcinoma following pancreaticoduodenectomyMasashi Tsunematsu, Koichiro Haruki, Tomohiko Taniai, et al.
Molecular Cancer Therapeutics|November 28, 2022
High-Throughput Functional Evaluation of MAP2K1 Variants in CancerSho Mizuno, Masachika Ikegami, Takafumi Koyama, et al.
Surgery Today|August 20, 2024
Prognostic impact of abdominal aortic calcification in patients who underwent hepatectomy for intrahepatic cholangiocarcinomaYuto Yamahata, Takeshi Gocho, Kenei Furukawa, et al.
International Journal of Clinical Oncology|July 9, 2026
Preoperative prediction of vessels encapsulating tumor clusters in hepatocellular carcinoma based on CT findings and des-γ-carboxy prothrombin levelTomohiko Taniai, Koichiro Haruki, Megumi Shiraishi, et al.
Surgical Oncology|September 28, 2023
Superior mesenteric vein/portal vein contact in preoperative imaging indicates biological malignancy in anatomically resectable pancreatic cancerYoshihiro Shirai, Shinji Onda, Yoshiaki Tanji, et al.
Surgery Today|January 6, 2026
Impact of thyroid-stimulating hormone ratio change on the progression-free survival of patients receiving gemcitabine, cisplatin, and durvalumab therapy for advanced biliary tract cancerMichinori Matsumoto, Shinji Itoh, Masashi Tsunematsu, et al.
Pageof 7